tirzepatide obstructive sleep apnea Original Article: for the Treatment of and Obesity (SURMOUNT-OSA) buff.ly/4ccuPKO Editorial: Entering a New Era in Sleep-Apnea Treatment buff.ly/3XyX1D2 Obstructive sleep apnea with obesity:

Have a BMI of 27 or higher with weight-related health conditions Have a BMI of 30 or higher, even without other medical conditions Have established cardiovascular disease (such as a history of heart attack, stroke, or related conditions), as Wegovy is FDA-approved to reduce the risk of serious heart problems in adults with obesity or overweight Struggle with appetite, cravings, or weight regain after diets Have other risk factors such as high body fat percentage or an increased waist circumference even if your BMI is in the normal range Wegovy HD (Semaglutide 7.2 mg Injection) Wegovy HD is the highest-dose injectable formulation of semaglutide, designed for patients who have progressed through the standard Wegovy dose schedule and need additional support to reach their goals

It is NOT expected to be approved by the FDA until 2027 or 2028

Regulatory bodies are fast-tracking approvals for GLP-1s to address their growing health burden

Its been less than a month and lost 6 pounds Feeling great Love this little shot

If it freezes, dont use it